Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA).
Candida albicans can readily form biofilms on both inanimate and biological surfaces. In this study we investigated a means of inhibiting biofilm formation using EDTA (Ethylenediaminetetra-acetic acid), a divalent cation chelating agent, which has been shown to affect C. albicans filamentation. Candida albicans biofilms were formed in 96-well microtitre plates. Cells were allowed to adhere for 1, 2, and 4 h at 37 degrees C, washed in PBS, and then treated with different concentrations of EDTA (0, 2.5, 25, and 250 mM). EDTA was also added to the standardized suspension prior to adding to the microtiter plate and to a preformed 24 h biofilm. All plates were then incubated at 37 degrees C for an additional 24 h to allow for biofilm formation. The extent and characteristics of biofilm formation were then microscopically assessed and with a semi-quantitative colorimetric technique based on the use of an XTT-reduction assay. Northern blot analysis of the hyphal wall protein (HWP1) expression was also monitored in planktonic and biofilm cells treated with EDTA. Microscopic analysis and colorimetric readings revealed that filamentation and biofilm formation were inhibited by EDTA in a concentration dependent manner. However, preformed biofilms were minimally affected by EDTA (maximum of 31% reduction at 250 mM). The HWP1 gene expression was reduced in EDTA-treated planktonic and biofilm samples. These results indicate that EDTA inhibits C. albicans biofilm formation are most likely through its inhibitory effect on filamentation and indicates the potential therapeutic effects of EDTA. This compound may serve a non-toxic means of preventing biofilm formation on infections with a C. albicans biofilm etiology.
Ramage
Gordon
G
Section of Infection and Immunity, Glasgow Dental School and Hospital, The University of Glasgow, Glasgow, UK.
Wickes
Brian L
BL
López-Ribot
José L
JL
D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development; D015152:Blotting, Northern; D002176:Candida albicans / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D002614:Chelating Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000382:microbiology*; D004492:Edetic Acid / Q000494:pharmacology*; D005656:Fungal Proteins / Q000737:chemistry / Q000235:genetics; D006801:Humans; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000235:genetics; D012313:RNA / Q000737:chemistry / Q000235:genetics
D002614:Chelating Agents; D005656:Fungal Proteins; C118102:HWP1 protein, Candida albicans; D008562:Membrane Glycoproteins; D012313:RNA; D004492:Edetic Acid